Imaging in Cancer Drug Development
Copthorne Tara Hotel
Scarsdale Place
London, London
Imaging in Cancer Drug Development  
SMI Conferences
Copthorne Tara Hotel

Schedule of Presentations:

Wednesday, March 14, 2012
08:30:00 Registration & Coffee
09:00:00 Chairman's Opening Remarks Gabriela Grigorean
09:10:00 Molecular imaging for cancer drug development Gabriela Grigorean
09:50:00 Imaging in cancer drug development – Clinical trial regulation in the EU Brian Davis
10:30:00 Morning Coffee
11:00:00 VISCOVER™: innovative contrast agents for in vivo small animal imaging in drug discovery
11:40:00 Translational imaging to improve probability of success in drug development Yanping Luo
12:20:00 PET imaging with radiolabeled monoclonal antibodies and tyrosine kinase inhibitors: Immuno-PET and TKI-PET Guus van Dongen
13:50:00 Networking Lunch
14:30:00 Contrast-enhanced ultrasound: new opportunities in drug development and clinical practice Francois Tranquart
15:10:00 A powerful new imaging modality for cancer research: Multispectral Optoacoustic Tomography (MSOT) Christian Wiest
15:40:00 Enhanced Bioluminescence pre-clinical imaging with engineered Luciferases and novel Luciferin analogues Martin Pule
16:20:00 Afternoon tea
16:40:00 Translational imaging in oncology: conventional and novel imaging biomarker use for discovery and development
17:10:00 Oncology translational imaging for early phase anticancer drug development
17:40:00 Chairman's Closing Remarks and Close of Day One
Thursday, March 15, 2012
06:00:00 New Presentation Werner Scheuer,
08:30:00 Registration & Coffee
09:00:00 Chairman's Opening Remarks Werner Scheuer,
09:10:00 Non-invasive imaging of barriers to drug delivery Simon Walker-Samuel
09:50:00 Non-invasive imaging of lung tumours in preclinical models
10:30:00 Morning Coffee
11:00:00 Changes in tumour T1 as an example of a useful early response marker to therapy
12:20:00 Networking Lunch
13:50:00 Multi-centre imaging in the context of clinical trials
14:30:00 Comprehensive data and image management tool for multicenter clinical trials
15:10:00 Afternoon Tea
15:40:00 Analysis of problems experienced by pharmaceutical companies handling oncology imaging
16:20:00 Understanding the value of your product
17:00:00 Chairman’s Closing Remarks and Close of Day Two
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.